Simultaneous inhibition of cholesterol absorption and synthesis in combined therapy with ezetimibe and simvastatin
This review is devoted to pharmacological characteristics, action mechanisms, hypolipidemic activity, and pleiotropic effects of a new hypolipidemic medication – ezetimibe, inhibiting intestinal cholesterol absorption. The combination of ezetimibe with other hypolipidemic drugs (statins, fibrates, b...
Main Author: | D. M. Aronov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2005-08-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/993 |
Similar Items
-
Ezetimibe potential in cardiology practice
by: A. A. Lyakishev, et al.
Published: (1970-01-01) -
Randomised study of ezetimibe, start doses of original statins, and their combination in patients with coronary heart disease and hyperlipidemia Part 2. Therapy effects on the levels of C-reactive protein and proinflammatory cytokines
by: A. V. Susekov, et al.
Published: (2011-12-01) -
ESCADRA: a randomised study. Part I: lipid-lowering effectiveness, safety and tolerability of ezetimibe, initial doses of original statins, and the combination of ezetimibe with initial doses of statins in patients with coronary heart disease and hyperlipidemia
by: M. Yu. Zubareva, et al.
Published: (2010-12-01) -
TREATMENT OF PATIENTS WITH SEVERE DYSLIPIDEMIA IN REAL CLINICAL PRACTICE
by: V. A. Korneva, et al.
Published: (2015-09-01) -
Комплаенс больных, получающих гиполипидемическую терапию
Published: (2018-06-01)